Nature Index data show China's share of biomedical-engineering papers nearly doubles since 2021
Nature Index figures for 2021-2025 show global biomedical-engineering output growing 70%, faster than the database overall, with the field's share of all tracked papers rising from 2.4% to 2.7%. China's contribution to that output jumped from 28.9% to 50.9%, while the US and Germany held second and third place with roughly steady shares. The analysis also highlights South Korea, Switzerland, Canada and the Netherlands as countries with distinct patterns of specialization, growth or international collaboration in the field.